Correction: Allogeneic hematopoietic stem cell transplantation for relapsed acute myeloid leukemia in ETO positive with reduced-intensity conditioning

Zhi Guo; Xiao-dong Liu; Hui-ren Chen

doi:10.18632/oncotarget.26806

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Corrections:

Correction: Allogeneic hematopoietic stem cell transplantation for relapsed acute myeloid leukemia in ETO positive with reduced-intensity conditioning

PDF | How to cite

Oncotarget. 2019; 10:2235-2235. https://doi.org/10.18632/oncotarget.26806

Metrics: PDF 1248 views | ?

Zhi Guo^1,2, Xiao-dong Liu² and Hui-ren Chen²

¹ Department of Medical Oncology, National Cancer Center/Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, 518116, China
² Department of Hematology, PLA Army General Hospital, Beijing, 100700, China

Correspondence to: Zhi Guo, email: [email protected]

Published: March 15, 2019

This article has been corrected: The correct author information, author affiliation and Corresponding author details are given below:

Zhi Guo^1,2, Xiao-dong Liu² and Hui-ren Chen²

Original article: Oncotarget. 2018; 9:524-538. DOI: https://doi.org/10.18632/oncotarget.22612.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 26806

Publication Alerts

Post-Publication Promotion

Publication Discount

Corrections:

Correction: Allogeneic hematopoietic stem cell transplantation for relapsed acute myeloid leukemia in ETO positive with reduced-intensity conditioning